Intranasal vaccines are showing promise, but there are multiple formulation hurdles to overcome.

Getting a Nose for Vaccines

The delivery platform depends on API-related factors, and the development stage of the product.

Platform Decisions for Inhalation Drugs

Topic

Articles

EMA's CHMP has approved two new manufacturing sites and a ready-to-use formulation of Comirnaty.

EMA Approves Two New Manufacturing Sites and a New Formulation for Comirnaty

EMA has started its evaluation of further expanded use of Comirnaty in children aged between five years and 11 years old.

EMA Starts Evaluation of Comirnaty in Children

In this collaboration, Takeda will utilize Poseida's biodegradable DNA and RNA nanoparticle delivery technology and other proprietary genetic engineering platforms for the research and development of gene therapies.

Poseida Therapeutics and Takeda Partner to Develop Non-Viral In-Vivo Gene Therapy Programs

Jennifer Markarian is manufacturing editor of Pharmaceutical Technology.

Conventional and robotic automation inside closed systems reduces risk. 

Automating Aseptic Manufacturing

Evolving equipment designs meet the unique needs of continuous processing techniques.

Adopting Continuous Manufacturing for Solid-Dose Drug Products

Alternatives to animal testing and in-vivo assays are occurring as a result of recent scientific advances.

In Vivo Falls Behind In Vitro for Adventitious Agent Testing

In an amendment to their existing contract manufacturing agreement, Celsian and Poly Pharm expand GEN-1 program collaboration to add clinical and commercial batches of investigational vaccine.

Celsion and Poly Pharm to Manufacture Celsion’s DNA-Based Vaccine

New data finds J&J COVID-19 vaccine and booster to provide increased protection against COVID-19. 

Real-World Evidence Shows Strong Protection from COVID-19 with J&J Vaccine and Booster

Considering interactions and understanding regulatory requirements are crucial when developing a drug or biologic product for use with a medical device.

Understanding Combination Product Regulations

When designing and manufacturing a pMDI or DPI combination drug-delivery device, the commercial stage should be kept in mind from the beginning of development.  

Dosage Forms

Getting a Nose for Vaccines

Platform Decisions for Inhalation Drugs